News Details
One stop modern building materials solution expert
Loquat Leaf Extract Emerges as a Key Ingredient in Respiratory Care
2026-06-23
Driven by the ongoing ingredient upgrades in China's traditional Chinese medicine (TCM) manufacturing, Loquat Leaf Extract—derived from the traditional herb through modern purification and deep-processing technologies—is now widely used in the clinical production of respiratory medications. Backed by definitive efficacy in nourishing the lungs, relieving coughs, reducing inflammation, and alleviating asthma, it has solidified its position as a core raw material for respiratory TCM drugs, propelling the modernization and medical upgrading of traditional herbal medicines.

According to the Chinese Pharmacopoeia, Loquat Leaf has historically been a classic herb for clearing lung heat, harmonizing the stomach, descending Qi, and resolving phlegm. Modern analytical testing confirms that its core active compounds include ursolic acid, oleanolic acid, amygdalin, and loquat leaf flavonoids. These compounds effectively relieve bronchial spasms, thin mucus, and inhibit the proliferation of harmful respiratory flora. They have proven clinical efficacy in managing conditions such as lung-heat cough, sore throat, chronic bronchitis, and prolonged coughing. Compared to synthetic antitussive chemicals, loquat leaf extract is gentle and non-addictive, making it suitable for a wide range of patients, including the elderly and adults.

Currently, mainstream over-the-counter (OTC) drugs on the market—such as Loquat Leaf Syrup, Fritillaria and Loquat Oral Liquid, antitussive granules, and throat lozenges—incorporate large quantities of Loquat Leaf Extract. This not only standardizes the content of active ingredients to ensure consistent therapeutic efficacy but also eliminates the cumbersome decoction process traditionally associated with raw TCM herbs. Industry R&D experts note that as the prevalence of chronic respiratory diseases continues to rise, the demand for medical-grade loquat leaf raw materials is increasing year by year. Looking ahead, further development of innovative lung-care formulations will continue to expand its clinical application boundaries.
Previous: